GOLL JOHN
SVP, FINANCE & CAO
GOLL JOHN has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 19, 2026.
On the most recent filing, GOLL JOHN is listed as SVP, FINANCE & CAO at Immunocore Holdings plc. Inside the rolling window, GOLL JOHN reported no open-market purchases and 1 open-market sale totaling $23K in IMCR.
Companies traded
Other insiders at IMCR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$23K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GOLL JOHN made?
GOLL JOHN has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does GOLL JOHN trade?
GOLL JOHN has filed SEC Form 4 disclosures for 1 company, including IMCR.
When was GOLL JOHN's most recent SEC Form 4 filing?
GOLL JOHN's most recent SEC Form 4 filing on Tracefour is dated Feb 19, 2026.
What is GOLL JOHN's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, GOLL JOHN is listed as SVP, FINANCE & CAO.
What is GOLL JOHN's total buy and sell value in the current window?
Inside the rolling retention window, GOLL JOHN bought $0 and sold $23K based on SEC Form 4 filings.
What was GOLL JOHN's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 698 IMCR shares on 2026-02-18, worth $23K, per SEC Form 4 filings.